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Abstract
Objective: To develop a model to simulate visual fields (VFs) in glaucoma patients, and to characterize variability of the
Mean Deviation (MD) VF summary measurement using real VFs and simulations.
Methods: Pointwise VF variability was previously approximated using longitudinal VF data (24–2 SITA Standard, Humphrey
Field Analyzer) from 2,736 patients; these data were used to build a non-parametric model to simulate VFs. One million VF
simulations were generated from 1,000 VFs (1,000 simulations per ‘ground-truth’ VF), and the variability of simulated MDs
was characterized as a function of ground-truth MD and Pattern Standard Deviation (PSD).
Results: The median (interquartile range, IQR) patient age and MD was 66 (56 to 75) years and23.5 (28.3 to21.1) decibels,
respectively. The inferred variability as a function of ground-truth MD and PSD indicated that variability, on average,
increased rapidly as glaucoma worsened. However, the pattern of VF damage significantly affects the level of MD variability,
with more than three-fold differences between patients with approximately the same levels of MD but different patterns of
loss.
Conclusions: A novel approach for simulating VFs is introduced. A better understanding of VF variability will help clinicians
to differentiate real VF progression from measurement variability. This study highlights that, overall, MD variability increases
as the level of damage increases, but variability is highly dependent on the pattern of VF damage. Future research, using VF
simulations, could be employed to provide benchmarks for measuring the performance of VF progression detection
algorithms and developing new strategies for measuring VF progression.
Citation: Russell RA, Garway-Heath DF, Crabb DP (2013) New Insights into Measurement Variability in Glaucomatous Visual Fields from Computer Modelling. PLoS
ONE 8(12): e83595. doi:10.1371/journal.pone.0083595
Editor: Demetrios Vavvas, Massachusetts Eye & Ear Infirmary, Harvard Medical School, United States of America
Received May 30, 2013; Accepted November 13, 2013; Published December 30, 2013
Copyright:  2013 Russell et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded in part by the UK National Institute for Health Research (NIHR) Health Services Research program (project number 10/2000/68)
and the National Institutes of Health (NIH; grant number R01EY007716). RAR and DFG-H received a proportion of their funding from the Department of Health27
(22 to 30) dB s National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of
Ophthalmology. RAR is supported by an Investigator Initiated Research grant from Allergan, Inc. DFG-H’s chair at UCL is supported by funding from the
International Glaucoma Association. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: Please note that in the Acknowledgments, the authors state that lead author (RAR) was previously supported by an Investigator Initiated
Research grant from Allergan, Inc. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
* E-mail: david.crabb.1@city.ac.uk
Introduction
Glaucoma is the leading cause of irreversible blindness
worldwide [1], affecting more than 70 million people [2]. The
disease is characterized by damage to the optic nerve head and
retinal nerve fibers, which can often be observed using a slit-lamp
examination. Glaucoma is frequently, but not invariably, associ-
ated with raised intra-ocular pressure. Early detection is important
for blindness prevention, and regular monitoring for deterioration
(‘progression’) in vision is a fundamental aspect of clinical
management. The extent of damage to the visual field (VF),
which is the area of our vision in which objects can be seen, relates
to the reduction of vision-related quality of life in glaucoma
patients [3–5]. Glaucoma management aims to preserve the
patient’s vision and VF. Tests of vision, such as the VF test, are,
therefore, of considerable clinical importance. VF testing (also
known as perimetry) aims to locate damaged areas in a patient’s
field of vision using an automated machine that systematically
measures the patient’s ability to identify the presence of a small
spot of light at different locations in their VF (‘contrast sensitivity’).
Interpretation of results from standard automated perimetry (SAP)
is challenging because VF measurements are very variable, as
revealed by psychophysical experiments using frequency-of-seeing
(FOS) procedures [6–8] and test-retest clinical studies [9–16].
Variability of SAP measurements necessitates frequent monitoring
and/or a long period of time to accurately detect true disease
progression [17] [18].
There is no perfect technique for diagnosing glaucoma or
monitoring the disease. The lack of a definitive measurement
makes it very difficult to gauge the performance of instruments,
such as SAP, to evaluate glaucomatous progression. In particular,
quantitative assessment of any algorithm or test requires access to
ground truth, which is not available for the measurement of
contrast sensitivity in SAP. Hence, computer simulation provides a
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means for generating artificial VF data consistent with real results
obtained by SAP. For over twenty years, simple computer
simulations have been used to assess VF test strategies and
contrast simulated results with real VF data [18–26]. Simulation
provides a reproducible and adjustable way of investigating the
behavior of cross-sectional and longitudinal VF data in large
volumes. In a recent study, we explored the relationship between
VF variability and contrast sensitivity in VFs using a statistical
method to quantify heteroscedasticity in longitudinal data [27].
We investigated almost 15,000 VFs from over 2,700 patients tested
in standard clinic conditions. Approximately one million residuals
were extracted to characterize VF variability by sensitivity level by
fitting a linear model of pointwise sensitivity measurements
(measurements of contrast sensitivity at different locations in the
VF) against time of follow-up. The residuals associated with each
fitted-sensitivity level were used in the current study in order to
build a novel non-parametric computational model for generating
VF simulations.
Unlike previous VF simulations [18,25,26,28], our computer
model is non-parametric and simulates VF sensitivity using
empirical estimates of VF variability. In addition, previous
simulations [18,25,26] have been based on estimates of variability
in just tens of subjects in FOS studies [7], while our model is based
on VF variability in almost 3,000 clinic patients, constituting
almost one million data points. In this study, we describe the
model and apply it to generate one million VF simulations from
1,000 ‘ground-truth’ VFs (1,000 simulations per real VF). These
simulations were then analyzed to examine the variability
associated with the ‘Mean Deviation’ (MD) VF summary
measurement, as a function of the level of MD [29]. The MD is
a summary statistic, which measures the mean increase or decrease
of a patient’s overall VF compared to a person with healthy vision
of the same age. Another summary statistic, ‘Pattern Standard
Deviation’ (PSD), measures the irregularity of patients’ VFs. Large
PSD values tend to indicate localized damage; however, patients
with severe damage throughout their VF will have a relatively
small PSD measurement. Mean Deviation and PSD are routinely
used in clinical practice to identify glaucomatous defects and track
progression of the disease. Nevertheless, the relationship between
the levels of MD and PSD and the variability of MD is unclear.
Some reports suggest that MD variability is non-stationary,
increasing with disease severity in glaucoma patients [30–32].
However, no research to date has reported on the influence of
pointwise VF variability, and therefore, the pattern of VF damage,
on the variability of MD. A better understanding of MD variability
will help clinicians to decipher glaucomatous VF test results and
assess progression of this index.
Materials and Methods
Ethics statement
Patients’ data was anonymised prior to investigation and did not
contain personal or sensitive information. As such patients’ written
consent for their data to be used in the study was not required.
The study adhered to the tenets of the Declaration of Helsinki and
was approved by the research governance committee of City
University London, United Kingdom.
Study sample: VF variability
The study sample used to derive pointwise VF variability, which
forms the foundation of the simulation model, is described in detail
elsewhere [27]. In summary, a retrospective analysis of 14,887
anonymised VFs from 2,736 eyes from 2,736 patients (one eye
randomly selected from each patient) attending the Glaucoma
Clinics of Moorfields Eye Hospital, London between 1997 and
2009 was conducted. All VFs were carried out with the Humphrey
Field Analyzer (HFA; Carl Zeiss Meditec, Dublin, CA) using the
24–2 test pattern with a Goldmann size III target and the SITA
Standard testing algorithm. The median (interquartile range)
follow-up was 6 (5 to 7) VF tests spanning 5.5 (3.9 to 7.0) years.
Figure 1. Distributions of VF variability according to sensitivity levels (Y^ ): 0, 6, 14 and 22 dB. The blue line in the bottom right plot
illustrates a single simulated draw from this distribution.
doi:10.1371/journal.pone.0083595.g001
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The relationship between variability and measured-sensitivity was
analyzed by examining the residuals from linear regression of
pointwise sensitivity over time. Residuals from pointwise linear
regression of sensitivity (the Y variable in decibels (dB)) against
time (the X variable in years) were examined for each eye’s series
of VFs (2,736 eyes) using ordinary least squares linear regression
(OLSLR) and Tobit linear regression (TLR).[33] The residuals
extracted from linear regression were binned into single dBs bins
in the range [0 to 36] dB according to the fitted-sensitivity value
rounded to the nearest whole decibel; see Figure 1. The residuals
from OLSLR were then used to simulate pointwise VF sensitivity
in our model, described next. All test locations of a given patient
were included in the simulations.
Visual field simulations
The residuals extracted from OLSLR of longitudinal pointwise
VF sensitivity in [27] underpin our VF simulation model; given a
‘true’ sensitivity value, they tell us the range of measured-values
expected for any given test – thus allowing VF pointwise sensitivity
to be simulated. For example, to simulate VF sensitivity when the
‘true’ value is equal to 22 dB, we randomly sample from the
distribution of residuals associated with a fitted-sensitivity of 22 dB.
The simulation is demonstrated in the bottom right distribution of
Figure 1 (Y^ =22 dB); in this plot approximately 50,000 residuals
are associated with an OLSLR fitted-sensitivity bin of 22 dB while
the blue line signifies the result from randomly drawing a single
residual from the distribution. In this simulation, the VF sensitivity
at that one location would be equal to 18 dB because the sampled
residual was equal to 24.07 dB. In order to simulate an entire VF
test, sensitivities are simulated one-by-one for each point in the
entire VF; see Figure 2. Next, MDs and PSDs were calculated by
first transforming raw sensitivities to total deviation values using
published normative values describing the relationship between
age and sensitivity in healthy individuals [29]. The MD was then
Figure 2. Ground-truth VF (A). The left hand grid of numbers illustrates pointwise sensitivity for all 52 locations in the VF, while the right hand
image shows the corresponding grayscale plot. The variability of the shaded VF point (sensitivity equal to 22 dB) is indicated in the bottom right
distribution in Figure 1. Simulated VF (B) derived from ground-truth VF shown in panel A. The left hand plot illustrates simulated pointwise
sensitivities for all locations in the above VF, while the right hand image shows the corresponding grayscale plot. The shaded VF point (sensitivity
equal to 18 dB) was derived by the simulated draw shown in the bottom right distribution in Figure 1.
doi:10.1371/journal.pone.0083595.g002
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calculated as the weighted mean of the total deviation values, with
weights equal to the inverse of the variance observed at each VF
location in the healthy reference group; as shown in Figure 3 of
[29]. The PSD, on the other hand, was calculated as the weighted
standard deviation of the total deviation values, with weights also
derived from Figure 3 of [29]; this is identical to taking the
weighted standard deviation of the pattern deviation values. Blind
VF points (displayed as ‘‘,0’’ in the HFA printout) were coded as
0 dB.
One thousand simulated VFs were generated from each of
1,000 patients’ VFs (1,000 eyes) visiting Moorfields Eye Hospital
between 1997 and 2009. These patients were not included in the
analysis to establish pointwise VF variability in [27]. All VFs were
carried out with the HFA using the 24–2 test pattern with a
Goldmann size III target and the SITA Standard testing
algorithm. Simulated pointwise VF sensitivities were generated
via random sampling from the corresponding distributions of
residuals for each ‘true’ sensitivity; the process was iterated for all
52 VF test points (excluding locations in the blind spot) in order to
generate 1000 simulated VFs for every ground-truth VF. Finally,
entire HFA-like VF printouts including greyscales were generated
using custom-written R code; see Figure 3.
All statistical analyses and computational work (including VF
simulations) were carried out using custom-written software in the
open source programming language, R [34].
Results
Table 1 summarizes the characteristics of the 1,000 patients that
make up the 1,000 ground-truth VFs.
Measurement variability in pointwise VF sensitivity varies
significantly with the level of measurement; variability is small at
high sensitivity levels, but markedly increases as sensitivity
decreases to a level of 10 dB, where residuals span almost the
entire measurement range of the instrument. At sensitivities less
than 10 dB, the observed reduction in variability can be explained
by the limited measurement range of SAP (0 to 50 dB), as revealed
by the negative skew in the distributions at 0 dB and 6 dB levels in
Figure 1.
We investigated the relationship between MD variability, the
levels of MD and PSD, and the pattern of pointwise VF damage,
through simulation. Figure 4 shows the variability of MD,
according to the standard deviation (SD) of 1000 simulated VFs
(MDs), as a function of the ground-truth level of MD (see
Figure 4A) and PSD (see Figure 4B). The dashed dark blue lines in
Figure 4 indicates the locally weighted polynomial regression [35]
(‘LOESS’ regression), which gives an indication of how variability
changes, on average, with the change in level of MD. The red
lines, on the other hand, illustrate the results of fitting a second
order model with a quadratic predictor: MD in Figure 4A
(adjusted R2=0.55) and PSD in Figure 4B (adjusted R2=0.38).
Figure 4A suggests that variability tends to increase as the level of
MD reduces, with some evidence that variability peaks around
220 dB. Figure 4B suggests that variability tends to increase as the
level of PSD increases, with some evidence that variability peaks
around 8 dB. For VF loss associated with early glaucoma, where a
significant amount of MD loss is approximately defined as 22 dB,
variability is half that observed when MD is equal to 210 dB,
which corresponds to VF loss associated with moderate glaucoma
[36]. Interestingly, as demonstrated by the considerable scatter in
Figure 4A and 4B, the standard deviation varied more than three-
fold between patients with approximately the same levels of
ground-truth MDs, from about 0.2 dB to over 0.7 dB (see Patients
A and B in Figure 4C).
Discussion
Standard automated perimetry continues to be the yardstick for
detecting and monitoring glaucoma in clinical practice and clinical
trials of new therapies for the disease. Nonetheless, SAP is affected
by factors including learning effects and patient fatigue [37,38].
Measurement variability is also induced by estimation errors
associated with testing strategies, such as staircases, used in clinical
SAP [21,24]. Several studies have shown that a reduction in VF
sensitivity is accompanied by an increase in response variability
[9–16]. This combination of issues leads to considerable difficulties
in differentiating true VF change from inherent noise, making
glaucoma management and treatment decisions very challenging.
Characterizing properties of VF measurements and assessing
the performance of VF progression algorithms requires an
independent gold-standard, which is not available for retinal
contrast sensitivity. This problem is widely recognized in glaucoma
research and many substitute approaches of classifying ‘true’
glaucomatous progression have been attempted [24,39]. Visual
field models offer an alternative benchmark and permit large
amounts of data to be simulated, with known characteristics, for
subsequent analysis. In this way, the importance of different
variables on VF measurements can be identified. Visual field
simulations have previously been used in glaucoma research to
evaluate testing strategies and progression detection tools [18–
25,40]. However, earlier models have been based on limited VF
data, and so may not accurately reflect clinical VF measurements.
For instance, some models [18,25,26,28] have been based on a
linear equation for VF variability in [7], which was based on FOS
curves with absolutely no data below 10 dB. Furthermore, these
previous models have assumed that variability is Gaussian-
distributed. Conversely, our simulations are based on SAP results
from thousands of clinic patients, and empirical estimates of VF
variability. Importantly, our simulations do not model VF
variability as a Gaussian distribution, which is clearly not
appropriate from inspection of Figure 1. In particular, Figure 1A
Figure 3. Simulated VF shown as a HFA-like printout. The grid of numbers in the top left represent the simulated sensitivities; while the
adjacent grayscale plot provides a graphical representation of the VF (darker areas represent defects). The number grids below represent the
difference in the patient’s VF sensitivities and those of a healthy individual of the same age: without correction for a general reduction in retinal
sensitivity (‘Total Deviation’); and with correction (‘Pattern Deviation’). Below these two grids are probability maps, which indicate whether the
reductions in sensitivities are significant.
doi:10.1371/journal.pone.0083595.g003
Table 1. Characteristics of glaucoma patients’ ground-truth
VFs.
Measurement Median (interquartile range)
Age 66.0 (55.8 to 75.5) years
Mean Deviation 23.5 (28.3 to 21.1) dB;
2.5th to 97.5th percentile: 222.0 to 1.4 dB
Pattern Standard Deviation 2.8 (1.7 to 6.8) dB;
2.5th to 97.5th percentile: 1.2 to 12.1 dB
Pointwise sensitivity 27 (22 to 30) dB
doi:10.1371/journal.pone.0083595.t001
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demonstrates that VF sensitivity is truncated at 0 dB (hence a lack
of negative residuals), which is also evident in Figures 1B and 1C,
and to some extent in Figure 1D. Nevertheless, it is important to
note that our VF simulations do not include variables that can
account for factors such as patient fatigue, learning effects, test
reliability, technician experience, time of day, and seasonal effects
[37,38,41]. Thus, the magnitude of variability simulated may be
less than observed in clinical practice due to these other factors. It
is also worth noting that our model is based on empirical estimates
of VF variability derived from linear modeling of VF decay, which
is only an approximation to ‘true’ VF variability.
Mean Deviation is routinely used to summarize overall VF
damage in individual patients, as well as in groups of patients
enrolled in clinical studies [30]. Since the MD index is a weighted
average, it is less sensitive to localized glaucomatous damage in the
VF; however, as a summary statistic, the MD is robust to
measurement noise at individual locations. Previous research
suggests that MD variability increases as the level of MD decreases
[30–32], but, until now, no study has investigated the impact of the
pattern of VF damage on the variability of MD. In the absence of
computer simulations, such a study would be very difficult to carry
out using clinical data as it would be almost impossible to
disentangle the relationship between patient error, algorithm error
and other measurement errors.
We carried out computer simulations to investigate the
association between MD variability, the levels of MD and PSD,
and the pattern of VF damage. Figure 4A illustrates how MD
variability increases, on average, as the level of MD decreases, with
some evidence that variability peaks around 220 dB. Figure 4B
demonstrates a strong association between MD variability and
PSD values; larger PSD values, suggesting greater glaucomatous
VF damage, are associated, on average, with higher variability.
For VF loss associated with early disease (MD <22 dB),
variability is half that in moderate glaucoma (MD <210 dB)
[36]. More interestingly, variability varies more than three-fold
between some patients with approximately the same levels of
MDs, suggesting that the pattern of pointwise VF damage has a
significant impact on MD variability. This is supported by
examining the VFs of patients with roughly equivalent MD
damage but very different levels of variability; see Patients A and
B, and Patients C and D in Figure 4C. These grayscale VF plots
indicate that VFs with global diffuse damage (Patients A and D)
tend to be more variable than VFs with localised damage and
other regions that are healthy (Patients B and C) despite the MD
Figure 4. Mean Deviation variability according to level of damage, and grayscale plots for four ground-truth VFs. The MDs of Patients
A–D are 211.4, 211.5, 220.4 and 220.5 dB, respectively, while the corresponding standard deviations of MD are 0.72, 0.19, 0.25 and 0.66,
respectively.
doi:10.1371/journal.pone.0083595.g004
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levels being almost the same. It is also interesting to note that the
PSD values of these two pairs of patients hint at the differences in
MD variability. For example, the PSD of Patient A’s VF is less
than half that of Patient B’s yet the patients share roughly the same
level of MD; the PSD of Patient A’s VF is much smaller than that
of Patient B due to the diffuse rather than localized damage seen in
the VF of Patients A and B respectively. This highlights the
importance of measuring VF progression using individualized
rather than population-based criteria.
Recently, there has been renewed interest in the MD index.
Junoy-Montolio et al. [41] showed that VF locations which test
blind on consecutive tests may result in an underestimation of the
MD index, which could affect MD-based progression detection
algorithms [41]. Their results also suggest that censoring of
pointwise sensitivity measurements at blind locations leads to a
reduced dynamic range of MD, and therefore, reduced variability
of this index. Our results are thus in good agreement with those
from Junoy-Montolio et al., and we support their conclusion that
VF points that have been shown to be reproducibly blind do not
contribute to progression detection. Figure 4A suggests that, on
average, this occurs at approximately 220 dB, since MD
variability starts to decrease at this value. This is not surprising
given that many points in the VF will likely be perimetrically-blind
at this level of damage, leading to the shrunken dynamic range of
MD described above. In addition, the 220 dB cut-off correlates
with the point at which pattern deviation calculations are deemed
unreliable and are not shown in HFA printouts [30]. Furthermore,
Junoy-Montolio et al. showed that the number of VF points
discarded by the HFA ‘Guided Progression Analysis’ software
[42,43] increases with disease progression up to an MD of about
220 dB but decreases beyond that point [41].
Wall et al. recently investigated the relationship of MD and its
variability for Goldmann size III and size V stimuli [31]. They
determined that the repeatability of size V MD was slightly better
than size III, but variability increased with increasing damage for
both stimuli. Depending on the size of the stimulus and the
amount of VF damage, a change of 1.5 to 4 dB in MD is necessary
to be outside normal 95% confidence limits [31]. Our results
suggest that any confidence limits also need to consider the pattern
of VF damage and not just the amount of VF damage. Wall et al.
concluded their research by stating that ‘‘further work needs to be
done to determine criteria for identifying visual field change’’. We
believe that VF simulations provide an excellent means by which
to provide benchmarks for measuring the performance of VF
progression detection algorithms and developing new strategies for
measuring VF progression. For example, if assessing the rate of VF
damage using linear regression of MD over time, it may be
important to account for the non-stationary variability observed
with disease worsening in the regression.
Visual field variability leads to false-positive diagnoses of
progression when patients actually have stable glaucoma, which
may lead to needless treatment changes and costs to both patient
and healthcare provider [32]. Conversely, glaucomatous progres-
sion may be missed if clinicians deem any change is due to
inherent measurement noise. In this study, computer simulations
have allowed us to gain a better understanding of MD variability;
on average, MD variability increases as the VF becomes more
damaged. Thus, detecting progression in MD will tend to be more
difficult in patients with moderate or advanced glaucoma than in
patients with early disease. Consequently, it may be advantageous
to carry out more frequent VF testing in glaucoma patients with
worse MDs and/or diffuse damage. Progression detection is
exasperated by the fact that MD slope variability is related to
shorter follow-up duration – research suggests that the phenom-
enon of ‘positive slopes’ and ‘rapid progressors’ is partly due to too
short series of VFs [44–46]. This study also suggests that clinicians
should be aware that variability can vary more than three-fold
between patients with roughly equivalent MDs; in particular, we
observe that VFs with global diffuse damage tend to be more
variable than VFs with localized damage and other regions that
are healthy. This information may help clinicians to differentiate
glaucomatous VF test results and assess progression of this index.
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